Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The objective of this study is * To evaluate the efficacy of PRC-4016 by assessment of the percentage change in blood lipids and lipoprotein parameter from baseline after 12 weeks of treatment * To evaluate the safety of PRC-4016 as assessed by adverse events and other safety parameters
Epistemonikos ID: 98f7edd537653cd99a40a01a5a879c1c7d1004a4
First added on: May 11, 2024